Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emerald Health Therapeutics Inc EMHTF

Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.


OTCQB:EMHTF - Post by User

Comment by DanielDarden123on Jan 23, 2020 11:12am
192 Views
Post# 30588792

RE:RE:“In Our Favor” ???

RE:RE:“In Our Favor” ???rrr....,

The ~$19M payable to PSF is the result of the Supply Agreement not the D2 Option Agreement. You have the latter correct but have overlooked the former. EMH has admitted in their own prospectus that they are responsible for the lost cash flow from the Supply Agreement when they do not take their 40% of PSF’s production. Fixed Price - Realized Price = EMH Payable.
<< Previous
Bullboard Posts
Next >>